• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲酮可阻断酒精对质膜中κ-阿片受体的诱导作用。

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane.

作者信息

Terenius Lars, Oasa Sho, Sezgin Erdinc, Ma Yuelong, Horne David, Radmiković Mihajlo, Jovanović-Talisman Tijana, Martin-Fardon Remi, Vukojevic Vladana

机构信息

Karolinska Institutet.

Karolinska Institute.

出版信息

Res Sq. 2023 Jul 21:rs.3.rs-3091960. doi: 10.21203/rs.3.rs-3091960/v1.

DOI:10.21203/rs.3.rs-3091960/v1
PMID:37503185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10371157/
Abstract

Naltrexone (NTX), a homologue of the opiate antidote naloxone, is an orally active long-acting mu-opioid receptor (MOP) antagonist used in the treatment of opiate dependence. NTX is also found to relieve craving for alcohol and is one of the few FDA-approved drugs for alcohol use disorder (AUD). Reports that NTX blocks the actions of endogenous opioids released by alcohol are not convincing, suggesting that NTX interferes with alcohol actions by affecting opioid receptors. MOP and kappa-opioid receptor (KOP) are structurally related but functionally different. MOP is mainly located in interneurons activated by enkephalins while KOP is located in longer projections activated by dynorphins. While the actions of NTX on MOP are well established, the interaction with KOP and addiction is not well understood. We used sensitive fluorescence-based methods to study the influence of alcohol on KOP and the interaction between KOP and NTX. Here we report that alcohol interacts with KOP and its environment in the plasma membrane. These interactions are affected by NTX and are exerted both on KOP directly and on the plasma membrane (lipid) structures ("off-target"). The actions of NTX are stereospecific. Selective KOP antagonists, recently in early clinical trials for major depressive disorder, block the receptor but do not show the full action profile of NTX. The therapeutic effect of NTX treatment in AUD may be due to direct actions on KOP and the receptor environment.

摘要

纳曲酮(NTX)是阿片类解毒剂纳洛酮的同系物,是一种口服活性长效μ-阿片受体(MOP)拮抗剂,用于治疗阿片类药物依赖。人们还发现NTX可缓解对酒精的渴望,它是美国食品药品监督管理局(FDA)批准用于治疗酒精使用障碍(AUD)的少数药物之一。关于NTX阻断酒精释放的内源性阿片类物质作用的报道并不令人信服,这表明NTX通过影响阿片受体来干扰酒精的作用。MOP和κ-阿片受体(KOP)在结构上相关但功能不同。MOP主要位于由脑啡肽激活的中间神经元中,而KOP位于由强啡肽激活的较长投射中。虽然NTX对MOP的作用已得到充分证实,但其与KOP的相互作用及成瘾机制尚不清楚。我们使用基于敏感荧光的方法来研究酒精对KOP的影响以及KOP与NTX之间的相互作用。在此我们报告,酒精与KOP及其在质膜中的环境相互作用。这些相互作用受NTX影响,并且既直接作用于KOP,也作用于质膜(脂质)结构(“脱靶”)。NTX的作用具有立体特异性。选择性KOP拮抗剂最近在治疗重度抑郁症的早期临床试验中,可阻断该受体,但未显示出NTX的完整作用谱。NTX治疗AUD的疗效可能归因于其对KOP和受体环境的直接作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/3e2263295864/nihpp-rs3091960v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/31109b07330a/nihpp-rs3091960v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/469ea05c8fe1/nihpp-rs3091960v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/b587795ae503/nihpp-rs3091960v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/3e2263295864/nihpp-rs3091960v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/31109b07330a/nihpp-rs3091960v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/469ea05c8fe1/nihpp-rs3091960v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/b587795ae503/nihpp-rs3091960v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0473/10371157/3e2263295864/nihpp-rs3091960v1-f0004.jpg

相似文献

1
Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane.纳曲酮可阻断酒精对质膜中κ-阿片受体的诱导作用。
Res Sq. 2023 Jul 21:rs.3.rs-3091960. doi: 10.21203/rs.3.rs-3091960/v1.
2
Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane.纳曲酮阻断了阿片受体κ 在质膜上的酒精诱导作用。
Transl Psychiatry. 2024 Nov 24;14(1):477. doi: 10.1038/s41398-024-03172-8.
3
Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.临床应用的κ-阿片受体激动剂纳呋拉啡联合小剂量纳曲酮可预防雄性和雌性小鼠的酒精复饮样饮酒。
Brain Res. 2019 Dec 1;1724:146410. doi: 10.1016/j.brainres.2019.146410. Epub 2019 Aug 27.
4
Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.κ阿片受体激动剂介导的抗伤害感受被δ受体激动剂阻断。
Br J Pharmacol. 2015 Jan;172(2):691-703. doi: 10.1111/bph.12810. Epub 2014 Sep 5.
5
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.促多巴胺调节剂(KB220PAM)与纳曲酮联合预防阿片类物质使用障碍复发的证据分析
EC Psychol Psychiatr. 2018 Aug;7(8):564-579. Epub 2018 Jul 30.
6
Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.在大鼠脊神经结扎模型中单神经病痛中 NOP、MOP、DOP 和 KOP 受体拮抗剂的选择性分析。
Eur J Pharmacol. 2018 May 15;827:41-48. doi: 10.1016/j.ejphar.2018.03.008. Epub 2018 Mar 8.
7
Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.临床应用 κ-阿片受体激动剂纳呋拉啡与低剂量纳曲酮联合使用可减少雄性和雌性小鼠的过度饮酒。
Alcohol Clin Exp Res. 2019 Jun;43(6):1077-1090. doi: 10.1111/acer.14033. Epub 2019 May 2.
8
Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.免疫细胞和神经胶质细胞中的阿片受体——对疼痛控制的影响。
Front Immunol. 2020 Mar 4;11:300. doi: 10.3389/fimmu.2020.00300. eCollection 2020.
9
Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.阿片类拮抗剂对小鼠神经母细胞瘤的调节作用:细胞增殖及阿片肽和受体的概况
Brain Res. 1989 Feb 20;480(1-2):16-28. doi: 10.1016/0006-8993(89)91562-x.
10
Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.孤啡肽/强啡肽 N 端前体(NOP)和μ阿片受体(MOP)激活均有助于塞布那肽在大鼠中的辨别刺激特性。
Neuropharmacology. 2018 Feb;129:100-108. doi: 10.1016/j.neuropharm.2017.11.026. Epub 2017 Nov 16.